Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Research and Development Agreements - Schedule of Contract Assets and Contract Liabilities for Performance Obligations related to Collaboration Agreements (Detail)

Research and Development Agreements - Schedule of Contract Assets and Contract Liabilities for Performance Obligations related to Collaboration Agreements (Detail) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Contract Liabilities
Deferred revenue	$ 6,350	$ 2,765
ASC 2014-09
Contract Assets
Unbilled revenue	54	0
Contract Liabilities
Deferred revenue	$ 4,929	$ 1,092

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References + Details